How Can We Improve Current Practice in Spastic Paresis?
LONDON, January 17, 2017 /PRNewswire/ —
Klemens Fheodoroff, Jorge Jacinto, Alexander Geurts, Franco Molteni, Jorge Hernández Franco, Tharaga Santiago, Raymond Rosales, Jean-Michel Gracies; European Neurological Review, 2016;11(2):79-86 DOI: https://doi.org/10.17925/ENR.2016.11.02.79
Published recently in European Neurological Review, the peer-reviewed journal from touchNEUROLOGY, Klemens Fheodoroff et al, review how the positive, negative and biomechanical symptoms associated with spastic paresis can significantly affect patients’ quality of life, by impairing their ability to perform normal activities. This paper – based on the content of a global spasticity interdisciplinary masterclass presented by the authors for healthcare practitioners working in the field of spastic paresis – proposes a multidisciplinary approach to care involving not only healthcare practitioners, but also the patient and their family members/carers, and improvement of the transition between specialist care and community services. The suggested treatment pathway comprises assessment of the severity of spastic paresis, early access to neurorehabilitation and physiotherapy and treatment with botulinum toxin and new technologies, where appropriate. To address the challenge of maintaining patients’ motivation over the long term, tailored guided self-rehabilitation contracts can be used to set and monitor therapeutic goals. Current global consensus guidelines may have to be updated, to include a clinical care pathway related to the encompassing management of spastic paresis.
The full peer-reviewed, open-access article is available here:
https://doi.org/10.17925/ENR.2016.11.02.79
Disclosure: Preparation of this paper was supported by Ipsen. The authors are responsible for the content of the paper. Ipsen did not contribute to the content of the manuscript, with the exception of a courtesy review. Klemens Fheodoroff has received unrestricted research grants from Ipsen and Merz, and honoraria for instructional courses from Ipsen, Allergan and Merz. Jorge Jacinto has received unrestricted research grants, as well as honoraria for instructional courses, conferences and advisory boards from Ipsen, Allergan and Merz. Alexander Geurts has received unrestricted research grants from Ipsen and Merz, and honoraria for instructional courses from Ipsen. Franco Molteni has received unrestricted research grants from Ipsen and Merz and honoraria for instructional courses from Ipsen, Allergan and Merz. Jorge Hernández Franco reports no conflicts of interest. Tharaga Santiago reports no conflicts of interest. Raymond Rosales has received unrestricted research grants, as well as honoraria for instructional courses, conferences and advisory boards from Ipsen and Allergan. Jean-Michel Gracies has served as a consultant and received research grant support from Allergan, Ipsen and Merz.v
Note to the Editor
touchNEUROLOGY (a division of Touch Medical Media) publishes
European Neurological Review, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of neurology. The aim of these reviews is to break down the high science from ‘data-rich’ primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
https://www.touchNEUROLOGY.com
For inquires please contact:
Carla Denaro – Managing Editor
T: +44 (0) 207 193 6093
managingeditor@touchmedicalmedia.com
Providing practical opinion to support best practice for busy healthcare professionals.
LONDON, January 17, 2017 /PRNewswire/ —
Klemens Fheodoroff, Jorge Jacinto, Alexander Geurts, Franco Molteni, Jorge Hernández Franco, Tharaga Santiago, Raymond Rosales, Jean-Michel Gracies; European Neurological Review, 2016;11(2):79-86 DOI: https://doi.org/10.17925/ENR.2016.11.02.79
Published recently in European Neurological Review, the peer-reviewed journal from touchNEUROLOGY, Klemens Fheodoroff et al, review how the positive, negative and biomechanical symptoms associated with spastic paresis can significantly affect patients’ quality of life, by impairing their ability to perform normal activities. This paper – based on the content of a global spasticity interdisciplinary masterclass presented by the authors for healthcare practitioners working in the field of spastic paresis – proposes a multidisciplinary approach to care involving not only healthcare practitioners, but also the patient and their family members/carers, and improvement of the transition between specialist care and community services. The suggested treatment pathway comprises assessment of the severity of spastic paresis, early access to neurorehabilitation and physiotherapy and treatment with botulinum toxin and new technologies, where appropriate. To address the challenge of maintaining patients’ motivation over the long term, tailored guided self-rehabilitation contracts can be used to set and monitor therapeutic goals. Current global consensus guidelines may have to be updated, to include a clinical care pathway related to the encompassing management of spastic paresis.
The full peer-reviewed, open-access article is available here:
https://doi.org/10.17925/ENR.2016.11.02.79
Disclosure: Preparation of this paper was supported by Ipsen. The authors are responsible for the content of the paper. Ipsen did not contribute to the content of the manuscript, with the exception of a courtesy review. Klemens Fheodoroff has received unrestricted research grants from Ipsen and Merz, and honoraria for instructional courses from Ipsen, Allergan and Merz. Jorge Jacinto has received unrestricted research grants, as well as honoraria for instructional courses, conferences and advisory boards from Ipsen, Allergan and Merz. Alexander Geurts has received unrestricted research grants from Ipsen and Merz, and honoraria for instructional courses from Ipsen. Franco Molteni has received unrestricted research grants from Ipsen and Merz and honoraria for instructional courses from Ipsen, Allergan and Merz. Jorge Hernández Franco reports no conflicts of interest. Tharaga Santiago reports no conflicts of interest. Raymond Rosales has received unrestricted research grants, as well as honoraria for instructional courses, conferences and advisory boards from Ipsen and Allergan. Jean-Michel Gracies has served as a consultant and received research grant support from Allergan, Ipsen and Merz.v
Note to the Editor
touchNEUROLOGY (a division of Touch Medical Media) publishes
European Neurological Review, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of neurology. The aim of these reviews is to break down the high science from ‘data-rich’ primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
https://www.touchNEUROLOGY.com
For inquires please contact:
Carla Denaro – Managing Editor
T: +44 (0) 207 193 6093
managingeditor@touchmedicalmedia.com
Providing practical opinion to support best practice for busy healthcare professionals.